Evidence map›Paper›PMID 32463024›Full record

ArticleIET nanobiotechnology2020

Analytical study of biosynthesised silver nanoparticles against multi-drug resistant biofilm-forming pathogens.

Wafa Badar, Muhammad Azmat Ullah Khan

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Biomedicines · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wafa BadarFaculty of Life Sciences, University of Central Punjab, Lahore, Pakistan.
Muhammad Azmat Ullah KhanDepartment of Biochemistry & Molecular Biology, University of Gujrat, Pakistan. mazmatullahkhan@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of the huge number of multi-drug resistant (MDR) bacteria requires an alternative to the drugs. Silver nanoparticles (AgNPs) are a strong candidate for this due to their bactericidal properties, which can be better concluded by understanding their morphology and chemistry. The study hypothesised that AgNPs synthesised using leaves of

Indexed as

Anti-Bacterial AgentsSilverA549 CellsAntineoplastic AgentsBacteriaBiofilmsCell SurvivalDrug Resistance, Multiple, BacterialHumansMetal NanoparticlesMicrobial Sensitivity TestsParticle SizeAnti-Bacterial AgentsAntineoplastic AgentsSilver

Identifiers

PMID32463024
PMCPMC8676042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.